US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Reach Resources Ltd (RR1OA) 銘柄情報

Reach Resources Ltd (RR1OA)

0.004

0.001

( 33.33% )

更新日時： 12:11:27

Reach Resources Ltd (RR1OA) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.004

( 33.33% )

買値

0.004

売値

0.005

出来高

2,699,000

0.004 日の範囲 0.004

0.003 52 週間の範囲 0.008

時価総額

前日終値

0.003

始値

0.004

時刻

最終取引時間

12:11:27

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 7,638,189

発行済株式数

966,192,962

配当利回り

PER

-11.72

1 株当たり利益 (EPS)

-0

歳入

-

純利益

-973.59k

Reach Resources Limited engages in the exploration and evaluation of mineral resource projects in Australia. It primarily explores for gold, rare earth elements, lithium, niobium, and manganese. The company was formerly known as Cervantes Corporation Limited. Reach Resources Limited was incorporated... Reach Resources Limited engages in the exploration and evaluation of mineral resource projects in Australia. It primarily explores for gold, rare earth elements, lithium, niobium, and manganese. The company was formerly known as Cervantes Corporation Limited. Reach Resources Limited was incorporated in 2001 and is based in Perth, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.reachresources.com.au

本社

Perth, Australia

設立

2026

Reach Resources Ltd is listed in the sector of the オーストラリア証券取引所 with ticker RR1OA. The last closing price for Reach Resources was AUD0. Over the last year, Reach Resources shares have traded in a share price range of AUD 0.003 to AUD 0.008.

Reach Resources currently has 966,192,962 shares in issue. The market capitalisation of Reach Resources is AUD3.86 million. Reach Resources has a price to earnings ratio (PE ratio) of -11.72.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.004	0.004	0.004	504547	0.004	DE
4	0	0	0.004	0.006	0.003	5474173	0.00487254	DE
12	0	0	0.004	0.006	0.003	4545917	0.00434918	DE
26	0	0	0.004	0.008	0.003	3418382	0.00456836	DE
52	0	0	0.004	0.008	0.003	2292812	0.00466495	DE
156	0.002	100	0.002	0.016	0.001	1564668	0.00497939	DE
260	0.002	100	0.002	0.016	0.001	1564668	0.00497939	DE

RR1OA - Frequently Asked Questions (FAQ)

What is the current Reach Resources Ltd share price?

The current share price of Reach Resources Ltd is AUD 0.004

How many Reach Resources Ltd shares are in issue?

Reach Resources Ltd has 966,192,962 shares in issue

What is the market cap of Reach Resources Ltd?

The market capitalisation of Reach Resources Ltd is AUD 3.86M

What is the 1 year trading range for Reach Resources Ltd share price?

Reach Resources Ltd has traded in the range of AUD 0.003 to AUD 0.008 during the past year

What is the PE ratio of Reach Resources Ltd?

The price to earnings ratio of Reach Resources Ltd is -11.72

What is the registered address of Reach Resources Ltd?

The registered address for Reach Resources Ltd is 216 St Georges Terrace, Perth, Western Australia, 6000

What is the Reach Resources Ltd website address?

The website address for Reach Resources Ltd is www.reachresources.com.au

ace65

WOW...just saw the eod Level II .WTF happened.
A high of .0037 million bought.

mrwrn2010

mrwrn2010 56秒前

Even more reason to transfer full Adderall rights to Elite . Methadone and Ropinirole alone ain’t gonna get us anywhere near the growth we need in the near term.

jour_trader

jour_trader 2分前

Also, #3 - should Elite sell or transfer ANDA…

mrwrn2010

mrwrn2010 3分前

It seems like Elite can amend the existing filing from a P IV to a P III if I’m reading the document correctly. So still, doesn’t make sense. Let us get the approval whenever and we’ll wait to launch as soon as those patents are up (assuming no one else has exclusivity).

Just give me $1.50

Just give me $1.50 5分前

Elite's attorneys are regarded, just like it's CEO.

We ain't launching Oxy until late 2028..........AT BEST.

jour_trader

jour_trader 6分前

I read that as submission to the FDA as in it buys Purdue even more time beyond the patent expiration date.

Lord Andreti

Lord Andreti 7分前

It’s far from going to no bid. Bid is high AF right now and not something you see daily around the OTC market.

Something is brewing and this is for sure going places (bid still gives the biggest tells)…I just don’t think it’s going be that big of a deal, anymore, after this crap.

OMOLIVES

OMOLIVES 8分前

Also, look at the past six Months. They had 7.5 - 1 Billion volume days over the past six Months. Backlog, bottleneck....fucked.

Just give me $1.50

Just give me $1.50 11分前

Does this mean every penny spent on this case was a complete waste of time since we can't launch until the patents are up?

Or in other words, we got absolutely nothing out of it, except losing money on attorney fees?

So Elite failed?

Thanks.

along4zride

along4zride 11分前

BIG IPO TOMORROW. Real company on major exchange. Excitement enthusiasm, whole world watching. Will be setting a benchmark for all going forward. Not some pink sheet (FNMA) wanna be has been in conservatorship with total profit sweep waiting for a hand out . Most can recognize the difference. I am

nowwhat2

nowwhat2 12分前

The 200 = Wow
https://schrts.co/CWanBemw

https://investorshub.advfn.com/uimage/uploads/2026/6/12/pynusbag_june_11_sweet_but_vol.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/dwwgnbag_june_11_snip_vol_nuts.jpg

https://i

Oleblue

Oleblue 14分前

Chad Williams, CEO of Honey Badger Silver Inc. | Rule Symposium 2026: Rick Rule interviews

https://youtu.be/zGol2-Jz7p8

Got Germanium and Tungsten?

Daily Chart
https://schrts.co/kbyFeMMu

JimBoStevens

JimBoStevens 17分前

That Weekly W% up and Sto down, while pinching OMFG spells KaBoom to me

Overall Market will be crazy tomorrow perfect timing... well see just dont see a better time then now

Just give me $1.50

Just give me $1.50 18分前

We have INDEED met the requirement of at least 10 likes.

Therefore, AS PROMISED, here are the documents (11 pages):

STIPULATION of Dismissal and Proposed Order Regarding Irrevocable Covenant Not to Come to Market by ELITE LABORATORIES, INC., ELITE PHARMACEUTICALS, INC.

jour_trader

jour_trader 19分前

That’s great insight. Thanks for sharing. At least 14 months away from launch and going into final stages of FDA decision. Wonder where Accord is in the process.

SSKILLZ1

SSKILLZ1 21分前

OPFI

The thing I really love about OPFI is this acquisition I believe this will be a game changer to profitability with a combo of product and geographic diversification, combined with a lower cost of funds. I simply think this acquisition going forward will be a strong tailwind to th

MonkRebel181

MonkRebel181 23分前

What’s another 20 years to see .50 again.

Dead money lies here. Invest in VOO and you’ll come out much farther ahead. This is a terrible investment that will not pay off for a century at this point.

Voo and chill people. Why park money in a dead stock that won’t see a 2

mrwrn2010

mrwrn2010 23分前

Now let’s see if the Lowenstein clown shows back up on this board anytime soon. Then there will be no doubt whatsoever that they were involved in this case. Lmao.

PRmaniac

PRmaniac 28分前

Yesterday’s FINRA short volume ratio came in at 45.35% on ~40M total volume. Almost half of the shares traded yesterday were short sales even with reg sho in effect.

Could go lower. We'll see.
Will we get a Friday slam? Market has not yet digested what I believe to be good new

BigB111

BigB111 30分前

I wonder who dumped the million shares today and who picked them up? 🤔 $TMMI

SSKILLZ1

SSKILLZ1 30分前

INTU

I don't know where your coming up with these numbers but they are just not right in my opinion.

The adjusted tax rate through 9 months ended was 24% roughly for both years.

Pretax income for FY 26 non gaap is roughly 14.4% for nine months ended so f

4retire

4retire 30分前

Once again a personal attack. You are predictable. Yes I said that if their CFO is given the power to control spending and capital projects then KULR could become viable. They have lacked discipline for years. They can’t continue burning through millions of dollars with minimal results..

mrwrn2010

mrwrn2010 31分前

Just bought the stipulation document off Pacer, cost me slightly over 3 ELTP shares at current price. Lol. Looks like they both agreed to drop the case and as part of that, Elite agreed to not market OxyContin until the patents in this case expire, which this document says “the Asserted Patents all

zzNine2Five

zzNine2Five 31分前

I used to think Goldman Sachs would be the pick, now I am suspect ing CITI as Goldman Sachs have their hands all over on a couple of mega AI IPOs.

Reach Resources

First National of Nebraska (ID)

Provaris Energy

BlackRock Institutional ...

Agnico Eagle Mines

Intesa Sanpaolo

ISE Clean Edge Water

Orbta 22-1.29 B

Euronext Transatlantic H...

Fidus Investment

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。